Skip to main content
. 2017 Jul 7;20(1):78–91. doi: 10.1093/neuonc/nox128

Fig. 5.

Fig. 5

Combination of BKM and MK1775 inhibited tumor growth in subcutaneous model. Mice with established flank xenografts were administered BKM (20 mg/kg/d), MK1775 (30 mg/kg/d), or combination. Tumor size was monitored by bioluminescence imaging (A–B) as well as being measured by caliper (C). The tissue sections were incubated with antibodies against pS473-Akt, pY15-Cdc2, γH2AX, cleaved caspase-3, and Ki-67 (D) and quantified by Image-Plus pro (E). Scale bars, 50 microns.